At a glance
ClinicalIndex Comparison RecordN/ACompleted· 621 enrolled
Drug / intervention
Tigecycline (Tygacil)drug
Likely dose
Tigecycline (Tygacil) 50 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Observational Study To Monitor Safety In Patients Who Were Administered With Tigecycline (Tygacil) 50 mg By Intravenous Injection (An Observational Study for Safety - Monitored Release)
In Brief
An observational study evaluating Tigecycline (Tygacil) for Complicated Skin and Skin Structure Infections and Complicated Intra-abdominal Infections. Completed, enrolled 621 participants across 1 site.
Detailed Summary
The purpose of this study is to collect post-marketing information on the safety of Tygacil in Filipino patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesPhilippines
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2007
First PostedMay 2008
Primary CompletionMay 2010
TodayJul 2026
First PostedMay 23, 2008
Enrollment StartApr 1, 2007
Primary CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 18.1 years ago
Interventions
Tigecycline (Tygacil)drug
This is a non-interventional study; patients are administered Tygacil as prescribed by their doctor as per registered indications stated in product label/insert (50 mg by Intravenous Injection).